Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Participation and survival of geriatric patients in Phase I clinical trials: the Karmanos Cancer Institute (KCI) experience.

Zafar SF, Heilbrun LK, Vishnu P, Jasti P, Venkatramanamoorthy R, Ding L, Lorusso PM, Heath EI.

J Geriatr Oncol. 2011 Jan 1;2(1):18-24.

2.

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy.

Hammad N, Heilbrun LK, Philip PA, Shields AF, Zalupski MM, Venkatramanamoorthy R, El-Rayes BF.

Asia Pac J Clin Oncol. 2010 Jun;6(2):98-105. doi: 10.1111/j.1743-7563.2010.01290.x.

3.

Sinonasal mucosal melanoma: a 13-year experience at a single institution.

Narasimhan K, Kucuk O, Lin HS, Heilbrun LK, Carron M, Venkatramanamoorthy R, Mathog R.

Skull Base. 2009 Jul;19(4):255-62. doi: 10.1055/s-0028-1115321.

4.

Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.

Choi M, Heilbrun LK, Venkatramanamoorthy R, Lawhorn-Crews JM, Zalupski MM, Shields AF.

Am J Clin Oncol. 2010 Jun;33(3):257-61. doi: 10.1097/COC.0b013e3181a76a0b.

5.

Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer.

Mobayed M, Heilbrun LK, Shields AF, Washington T, Venkatramanamoorthy R, Philip PA, El-Rayes BF.

Case Rep Oncol. 2009 Nov 21;2(3):220-228.

6.

Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer.

Gadgeel SM, Wozniak A, Ruckdeschel JC, Heilbrun LK, Venkatramanamoorthy R, Chaplen RA, Kraut MJ, Kalemkerian GP.

J Thorac Oncol. 2008 Nov;3(11):1293-300. doi: 10.1097/JTO.0b013e31818b194e.

7.

Effects of high fruit-vegetable and/or low-fat intervention on breast nipple aspirate fluid micronutrient levels.

Djuric Z, Chen G, Ren J, Venkatramanamoorthy R, Covington CY, Kucuk O, Heilbrun LK.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1393-9.

8.

Mature results of a phase II trial of gemcitabine/paclitaxel given every 2 weeks in patients with advanced non-small-cell lung cancer.

Wozniak AJ, Belzer K, Heilbrun LK, Kucuk O, Gadgeel S, Kalemkerian GP, Venkatramanamoorthy R, Kraut MJ.

Clin Lung Cancer. 2007 Mar;8(5):313-8.

PMID:
17562230
9.

Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.

El-Rayes BF, Zalupski MM, Manza SG, Rusin B, Ferris AM, Vaishampayan U, Heilbrun LK, Venkatramanamoorthy R, Shields AF, Philip PA.

Cancer Chemother Pharmacol. 2008 Feb;61(2):283-9. Epub 2007 Apr 12.

11.

CT-guided percutaneous cryotherapy of renal masses.

Littrup PJ, Ahmed A, Aoun HD, Noujaim DL, Harb T, Nakat S, Abdallah K, Adam BA, Venkatramanamoorthy R, Sakr W, Pontes JE, Heilbrun LK.

J Vasc Interv Radiol. 2007 Mar;18(3):383-92.

PMID:
17377184
12.

Relationships of psychosocial factors to dietary intakes of preadolescent girls from diverse backgrounds.

Djuric Z, Cadwell WF, Heilbrun LK, Venkatramanamoorthy R, Dereski MO, Lan R, Casey RJ.

Matern Child Nutr. 2006 Apr;2(2):79-90.

13.

A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.

El-Rayes BF, Zalupski MM, Shields AF, Ferris AM, Vaishampayan U, Heilbrun LK, Venkatramanamoorthy R, Adsay V, Philip PA.

Invest New Drugs. 2005 Dec;23(6):583-90.

14.

Effects of low-fat and/or high-fruit-and-vegetable diets on plasma levels of 8-isoprostane-F2alpha in the Nutrition and Breast Health study.

Chen G, Heilbrun LK, Venkatramanamoorthy R, Maranci V, Redd JN, Klurfeld DM, Djuric Z.

Nutr Cancer. 2004;50(2):155-60.

PMID:
15623461

Supplemental Content

Loading ...
Support Center